News

 

Corindus' CorPath GRX Approved for Neurovascular Interventions in Australia and New Zealand

July 17, 2019 -- Corindus Vascular Robotics, Inc. announced that it received approval from the Australian Therapeutic Goods Administration to commercialize its CorPath GRX sys…

DRASTICO Study Compares Drug-Eluting Technologies in Femoropopliteal Lesions

July 17, 2019 -- Findings from the DRASTICO study, which compared drug-coated balloons (DCBs) and drug-eluting stents (DESs) for treating complex femoropopliteal arterial lesi…

Study Compares Endovascular Strategies for Treating Femoropopliteal Disease

July 17, 2019 -- Rongzhou He, MD, et al conducted a study of restenosis prevention with drug-eluting stents (DESs) or covered stents (CSs) in femoropopliteal arterial occlusiv…

Safety and Efficacy Data Published for Teleflex's Manta Closure Device

July 12, 2019 -- Findings from SAFE MANTA, the pivotal clinical study to evaluate the safety and effectiveness of the Manta percutaneous vascular closure device (Teleflex), we…

CDRH Issues Guidance for Live Case Presentations During IDE Clinical Trials

July 11, 2019 -- The FDA Center for Devices and Radiological Health (CDRH) has issued a guidance document on live case presentations during investigational device exemption (I…

Keystone Heart to Distribute Vasorum's Celt ACD Vascular Closure Device

July 11, 2019 -- Keystone Heart Ltd. announced that it has entered into a distribution agreement with Ireland-based Vasorum Ltd. for sales and marketing of Vasorum's Celt …

Click here for more News coverage

Paclitaxel In PAD

Current Supplement

Sponsored by GORE & ASSOCIATES

Raising the Standards

for Dialysis Access Care

Current European Supplement

Sponsored by EUMEDICA

Thrombolysis for Peripheral Arterial Thrombosis

Leading French experts discuss the place of thrombolysis in the modern era.

Device Guide

This Device Guide offers a searchable, comprehensive listing of the available vascular interventional devices in the United States.

 

Featured Center

 

Embolization

 
Vascular Market Price  Change
Abbott Laboratories $87.49  -0.31%
AstraZeneca PLC $40.12  -1.50%
Avinger $2.37  -2.47%
Becton Dickinson and Co $250.84  -1.18%
Boston Scientific Corporation $42.25  -0.91%
Cardinal Health $44.99  -0.44%
Cardiovascular Systems Inc. $44.32  -0.36%
Edwards Lifesciences Corp. $194.33  0.65%
Endologix Inc. $6.68  -1.62%
Johnson and Johnson $130.31  -1.33%
Vascular Market Price  Change
Medtronic, Inc. $100.80  -0.53%
Merit Medical Systems, Inc. $55.02  -1.36%
Penumbra, Inc. $176.14  -0.41%
Philips $43.51  -1.45%
Ra Medical Systems $2.74  -0.72%
Silk Road Medical $41.70  0.87%
Stryker $208.02  -1.15%
Teleflex Inc. $335.05  -1.59%
The Medicines Company $36.06  -2.54%

@EVToday

Stay current: Follow Endovascular Today on Twitter @EVToday

Contact Info

For advertising rates and opportunities, contact:
Craig McChesney
484-581-1816
cmcchesney@bmctoday.com

Stephen Hoerst
484-581-1817
shoerst@bmctoday.com

Charles Philip
484-581-1873
cphillip@bmctoday.com

About Endovascular Today

Endovascular Today is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the endovascular field. Our Editorial Advisory Board is composed of the top endovascular specialists, including interventional cardiologists, interventional radiologists, vascular surgeons, neurologists, and vascular medicine practitioners, and our publication is read by an audience of more than 22,000 members of the endovascular community.